Targeting cytotoxic T lymphocytes for cancer immunotherapy

被引：80
|
作者：
Maher, J
Davies, ET
机构：
[1] Guys Hosp, Guys Kings & St Thomass Sch Med, Div Canc Studies, Canc Res UK Breast Canc Biol Grp, London SE1 9RT, England
[2] Kings Coll Hosp London, Rayne Inst, Dept Clin Immunol, London SE5 9NU, England
来源：
BRITISH JOURNAL OF CANCER | 2004年 / 91卷 / 05期
关键词：
CTL; vaccine; adoptive immunotherapy; gene therapy;
D O I：
10.1038/sj.bjc.6602022
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In light of their preeminent role in cellular immunity, there is considerable interest in targeting of cytotoxic T-lymphocytes to cancer. This review summarises the active and passive immunotherapeutic approaches under development to achieve this goal, emphasising how recent advances in tumour immunology and gene transfer have impacted upon this field.
引用
收藏
页码：817 / 821
页数：5
相关论文
共 50 条
  • [31] ACTIVATION OF T-LYMPHOCYTES FOR THE ADOPTIVE IMMUNOTHERAPY OF CANCER
    SUSSMAN, JJ
    SHU, S
    SONDAK, VK
    CHANG, AE
    ANNALS OF SURGICAL ONCOLOGY, 1994, 1 (04) : 296 - 306
  • [32] Engineering T lymphocytes with protein nanogels for cancer immunotherapy
    Tang, Li
    Zheng, Yiran
    Irvine, Darrell J.
    CANCER RESEARCH, 2014, 74 (19)
  • [33] Cytotoxic CD8+ T cells in cancer and cancer immunotherapy
    Hans Raskov
    Adile Orhan
    Jan Pravsgaard Christensen
    Ismail Gögenur
    British Journal of Cancer, 2021, 124 : 359 - 367
  • [34] Cytotoxic CD8+T cells in cancer and cancer immunotherapy
    Raskov, Hans
    Orhan, Adile
    Christensen, Jan Pravsgaard
    Gogenur, Ismail
    BRITISH JOURNAL OF CANCER, 2021, 124 (02) : 359 - 367
  • [35] Targeting of IL-2 to cytotoxic lymphocytes as an improved method of cytokine-driven immunotherapy
    Lazear, Eric
    Ghasemi, Reza
    Hein, Sarah M.
    Westwick, John
    Watkins, Dan
    Fremont, Daved H.
    Krupnick, Alexander Sasha
    ONCOIMMUNOLOGY, 2017, 6 (02):
  • [36] Targeting small cell lung cancer with virus-specific CD8+cytotoxic t lymphocytes
    Moss, A
    Aladin, F
    Marshall, E
    Blake, N
    Coulson, J
    LUNG CANCER, 2005, 49 : S138 - S138
  • [37] Lymph Node Delivery Strategy Enables the Activation of Cytotoxic T Lymphocytes and Natural Killer Cells to Augment Cancer Immunotherapy
    Jiang, Dandan
    Gao, Tong
    Liang, Shuang
    Mu, Weiwei
    Fu, Shunli
    Liu, Yang
    Yang, Rui
    Zhang, Zipeng
    Liu, Yongjun
    Zhang, Na
    ACS APPLIED MATERIALS & INTERFACES, 2021, 13 (19) : 22213 - 22224
  • [38] BCL2A1 neoepitope-elicited cytotoxic T lymphocytes are a promising individualized immunotherapy of pancreatic cancer
    Lin, Shengzhe
    Hong, Jingwen
    Wu, Suxin
    Zhu, Chenlu
    Liu, Fang
    Lin, Wansong
    Cai, Xinran
    Ye, Yunbin
    Chen, Yanling
    JOURNAL OF LEUKOCYTE BIOLOGY, 2024, 116 (03) : 601 - 610
  • [39] Mechanism of caspase independent activation induced cell death of human primary cytotoxic T lymphocytes: Implications for cancer immunotherapy
    Chhabra, A
    Mehrotra, S
    Chakraborty, NG
    Dorsky, DI
    Mukherji, B
    JOURNAL OF IMMUNOTHERAPY, 2005, 28 (06) : 651 - 652
  • [40] RESISTANCE OF CYTOTOXIC LYMPHOCYTES-T TO LYSIS BY A CLONE OF CYTOTOXIC LYMPHOCYTES-T
    KRANZ, DM
    EISEN, HN
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (10) : 3375 - 3379
12345